Pharmaceuticals - Community Register

  

List of refusals for human medicinal products

Xeljanz

Product name: Xeljanz
Active substance: tofacitinib
Indication: Treatment of rheumatoid arthritis in adult patients
Marketing Authorisation Holder: Pfizer Limited

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2013 Centralised - Refusal of marketing authorisation EMEA/H/C/2542 (2013)7873 of 08/11/2013